AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca uS 401(k) Plan — Total investment income / (loss) ($) ($)
Form 11-K Statements of Changes in Net Assets Available for Benefits
Latest, FY2025
1,264,091,746
Period ended Dec 31, 2025
Change on a year earlier
+13.5%
1,113,491,250 in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | US 401(k) Plan — Total investment income / (loss) ($) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,264,091,746 | +13.5% | Form 11-K FY2025 (AstraZeneca US 401(k) Plan) ↗ |
| FY2024 | Dec 31, 2024 | 1,113,491,250 | +7.1% | Form 11-K FY2024 (AstraZeneca US 401(k) Plan) ↗ |
| FY2023 | Dec 31, 2023 | 1,040,087,109 | -200.7% | Form 11-K FY2023 (AstraZeneca US 401(k) Plan) ↗ |
| FY2022 | Dec 31, 2022 | -1,033,349,786 | -204.0% | Form 11-K FY2022 (AstraZeneca US 401(k) Plan) ↗ |
| FY2021 | Dec 31, 2021 | 993,237,649 | +25.7% | Form 11-K FY2021 (AstraZeneca US 401(k) Plan) ↗ |
| FY2020 | Dec 31, 2020 | 789,970,376 | – | Form 11-K FY2020 (AstraZeneca US 401(k) Plan) ↗ |
Breakdown
What makes up us 401(k) plan — total investment income / (loss) ($)
Cite this data
StockData. (2026). AstraZeneca US 401(k) Plan — Total investment income / (loss) ($) ($), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/plan11k_total_inv_income
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.